临床表现 临床表现
Lara Huyghe1, Lisa Quenon1,2, Jean-Louis Bayart3,4
1Institute of Neuroscience, UCLouvain, Brussels, Belgium.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
血p-tau217和认知测试显示出早期阿尔茨海默病 (AD) 检测的前景. 将这些标记物结合起来,可以提高在未受损害个体中识别临床前AD病理的准确性.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 医疗成像医学成像
背景情况:
- 阿尔茨海默病 (AD) 诊断依赖于昂贵的粉样蛋白 (Aβ) 和tau-PET成像,限制了未受损的人群的查.
- 研究重点是用于预症状AD检测的负担得起的方法,包括认知指标和基于血液的生物标志物,如可溶性化陶 (p-tau).
- 对这些新兴标记物的对比比较和它们对早期AD检测的附加值很少.
研究的目的:
- 调查血p-tau217和认知任务在识别临床无障碍 (CU) 个体与阿兹海默症病理的PET成像证据的实用性.
- 为了比较血p-tau217的诊断性能和用于检测早期AD标志物的认知测试.
- 评估结合血生物标志物和认知措施用于早期AD检测的附加值.
主要方法:
- 80名CU老年人接受了血p-tau217测试,PET成像 (tau和粉样蛋白),MRI和神经心理评估,包括概念匹配任务 (CMT) 和视觉短期记忆绑定测试 (VSTMBT).
- 参与者根据粉样蛋白-PET (Aβ-/Aβ+) 或-PET (Tau-CU/Tau+CU) 状态进行分类.
- 用接收器操作特征 (ROC) 曲线来评估单个和组合标记的灵敏度,特异性和准确性.
主要成果:
- 血p-tau217表现出检测初始粉样化和形病的曲线下面面积 (AUC) 最高 (AUC=0.91).
- 在检测Aβ和tau-PET阳性的认知指标中,VSTMBT表现最好 (AUC=0.722和0.743,分别).
- 结合血p-tau217和认知标志物显著改善了AD病理的预测 (AUC=0.93对于Aβ,AUC=0.95对于tau),将tau-PET阳性的灵敏度提高到1.0,具有0.91的特异性.
结论:
- 血p-tau217和认知措施的结合为早期阿尔茨海默病诊断提供了一个有希望的,非侵入性的方法.
- 这种综合策略增强了在临床上不受损害的个体中检测临床前阿尔茨海默病理.
- 对这些组合生物标志物的进一步研究可能会导致对AD的更好的查和早期干预策略.
相关概念视频
01:24Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
01:30Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
01:25Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
01:26Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437